SCHEMBL310102

SCHEMBL310102

CCN1N=C(C)CC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28979903 0.80 ALDH1A1 (0.43)
SCHEMBL19237019 0.80
SCHEMBL4664754 0.79 GAA (0.89)
SCHEMBL2365151 0.78 ALDH1A1 (1.00)
SCHEMBL14208207 0.77 GAA (0.53)
SCHEMBL12862600 0.77 GAA (0.53)
SCHEMBL12194202 0.76
SCHEMBL11983638 0.75 ALDH1A1 (0.51)
SCHEMBL11205163 0.75 ALDH1A1 (0.51)
SCHEMBL16050086 0.75 GAA (0.49)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230330066-A1 Vasodilator and Use Thereof BIORADICAL RESEARCH INSTITUTE CORP. (JP) 2023-10-19 US disclosed
US-20230286921-A1 Method for Manufacturing Compound BIORADICAL RESEARCH INSTITUTE CORP. (JP) 2023-09-14 US disclosed
US-20230286921-A1 Method for Manufacturing Compound BIORADICAL RESEARCH INSTITUTE CORP. (JP) 2023-09-14 US disclosed
WO-2021125345-A1 VASODILATOR AND USE THEREOF 株式会社バイオラジカル研究所 2021-06-24 WO disclosed
US-20210128529-A1 DRUG CONTAINING PYRAZOLONE DERIVATIVE NOBELPHARMA CO., LTD. (JP) 2021-05-06 US disclosed
CN-112533991-A Rubber composition, rubber material, use thereof, and additive 大塚化学株式会社 2021-03-19 CN disclosed
CN-112118839-A Pyrazolone derivative-containing drug 耐贝医药株式会社 2020-12-22 CN disclosed
WO-2020158225-A1 ANTIOXIDANT AND USE THEREOF 株式会社バイオラジカル研究所 2020-08-06 WO disclosed
EP-3666270-A1 DRUG CONTAINING PYRAZOLONE DERIVATIVE Nobelpharma Co., Ltd. (JP) 2020-06-17 EP disclosed
EP-1793821-B1 PYRAZOLONE COMPOUNDS FOR TREATING CEREBROVASCULAR DISORDERS MITSUBISHI TANABE PHARMA CORP (JP) 2018-10-31 EP disclosed
US-20040254234-A1 Medicament for prevention and/or therapy of arterial wall disorder MITSUBISHI PHARMA CORPORATION (JP) 2004-12-16 US disclosed
EP-1437137-A1 DRUGS COMPRISING COMBINATION OF ANTITHROMBOTIC AGENT WITH PYRAZOLONE DERIVATIVE Mitsubishi Pharma Corporation (JP) 2004-07-14 EP disclosed
US-RE35801-E PYRAZOLONE DERIVATIVES MITSUBISHI CHEMICAL CORPORATION (JP) 1998-05-19 US disclosed
US-5461155-A Useful in dye diffusion transfer processes MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1995-10-24 US disclosed
US-5314998-A Dye-donor sheets for thermal printing MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1994-05-24 US disclosed
EP-0591016-A1 Organic solvent-soluble metal-azo and metal-azomethine dyes MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1994-04-06 EP disclosed
EP-0208874-B1 PROPHYLACTIC AND THERAPEUTIC AGENT FOR CIRCULATORY DISORDERS MITSUBISHI KASEI CORPORATION (JP) 1993-03-24 EP disclosed
US-4857542-A INHIBITOR AGAINST LIPID PEROXIDATION MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) 1989-08-15 US disclosed
EP-0240001-A1 2-Pyrazolin-5-ones and a process for production thereof NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1987-10-07 EP disclosed
EP-0208874-A1 Prophylactic and therapeutic agent for circulatory disorders MITSUBISHI KASEI CORPORATION (JP) 1987-01-21 EP disclosed